The skincare industry has a bioavailability problem. Many formulations contain biologically active ingredients — retinoids, peptides, growth factors — that have been shown to produce measurable results in laboratory conditions. But the skin is a barrier organ. Its outermost layer, the stratum corneum, is specifically designed to keep foreign molecules out. The result is that a significant proportion of topical actives never reach the dermal layers where collagen synthesis, cell division, and tissue repair actually occur.
This gap between ingredient potential and clinical outcome is one of the least discussed issues in modern skincare — and one of the most consequential.
The Delivery Problem
A compound’s molecular weight, lipophilicity, and encapsulation method all determine whether it can pass through the epidermal barrier in sufficient concentration to produce a physiological effect. Squalane-based delivery systems have emerged as one of the more effective vehicles, owing to squalane’s structural similarity to the skin’s own lipids, which allows it to carry active ingredients through the intercellular matrix rather than sitting on the surface.
Liposomal encapsulation offers another approach, wrapping actives in phospholipid bilayers that fuse with cell membranes. But not all delivery systems are equal, and few brands subject their formulations to objective penetration testing.
Measuring What Matters
This is where the distinction between cosmetic marketing and clinical methodology becomes critical. One Scandinavian skincare manufacturer — Beauté Pacifique, founded by a former ultrasound diagnostics engineer — has spent nearly three decades using dermal ultrasound scanning to measure changes in skin density and thickness before and after product use. The approach borrows directly from pharmaceutical trial methodology: if a product claims to reinforce the dermal-epidermal junction or stimulate collagen production, the effect should be visible on a scan — not just inferred from a consumer questionnaire.
Their most recent development, a patented fusion protein combining Epidermal Growth Factor with a chaperone peptide, was designed specifically to solve the penetration problem for biological signalling molecules. The chaperone functions as a molecular transport mechanism, reportedly enhancing EGF delivery tenfold compared to the growth factor applied alone.
Why This Matters for Longevity Medicine
For practitioners and patients approaching skincare as part of a broader healthspan strategy, the bioavailability question is not academic. Topical retinoids, antioxidants, and growth factors can play a meaningful role in maintaining the structural integrity of the skin — the body’s largest organ and one of its most reliable biomarkers of biological aging. But only if the active ingredients reach their target tissue in therapeutic concentrations.
The shift from marketing-led to measurement-led skincare may be one of the most important — and most overdue — developments in preventive dermatology.
This article was written for WHN by Ron, who is from VEED. He is a passionate content marketer with a wealth of knowledge in the online space. His curiosity and enthusiasm led to the development of a constantly expanding portfolio that includes anything from video editing services to publishing his original creations on top-notch websites.
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN neither agrees nor disagrees with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement.
Opinion Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy of WHN. Any content provided by guest authors is of their own opinion and is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything else. The Food and Drug Administration has not evaluated these statements.
https://worldhealth.net/news/everyday-skincare-challenges-aging-gracefully/
https://pubmed.ncbi.nlm.nih.gov/38481085
https://pubmed.ncbi.nlm.nih.gov/34779364
https://www.realsimple.com/beauty-fashion/skincare/where-does-skincare-go
https://worldhealth.net/news/combining-technology-and-tradition-innovative-anti-aging-techniques/
https://worldhealth.net/news/anti-aging-skincare-solution-works-in-testing/
https://worldhealth.net/news/adding_vitamins_to_skin_care_products_pr/
https://worldhealth.net/news/cosmetic-clinics-devices-safe-between-patient/
